Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026)
Odyssey Health's quarterly Total Non-Current Liabilities came in at $7.4 million in Q1 2026, up 4.34% quarter-over-quarter from $7.1 million in Q4 2025.
Odyssey Health has reported Total Non-Current Liabilities for 4 years, with the latest figure at $7.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $7.4 million; the trailing twelve-month figure through Jan 2026 stood at $7.4 million (changed N/A YoY), and the FY2025 full-year result was $7.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $7.4 million, up from $7.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $7.4 million in Q1 2026, with the low at $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Odyssey Health | - | - | - | 7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 7.38 Mn |
| Oct 31, 2025 | 7.07 Mn |
| Jul 31, 2025 | 7.00 Mn |
| Apr 30, 2020 | 1.36 Mn |
| Jan 31, 2020 | 1.19 Mn |
| Oct 31, 2019 | 1.07 Mn |
| Jul 31, 2019 | 986,203.00 |